Management attributed the 2025 revenue decline to a single legacy non-renewal from the Twill acquisition, characterizing it as a one-time event unrelated to core product value. The company achieved a record 85 new agreements in 2025, with average contract sizes ranging from two to 10 times larger than historical averages. Strategic growth is now driven by a 'compounding layer' model: channel partnerships provide ecosystem-level access to millions of lives, while the multi-condition platform increases ...

Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond the company’s control, including the risks described from time to time in its SEC filings. The company’s results may differ materially from those projections. These statements involve material risks and uncertainties that could cause actual results or events to differ materially. Accordingly, you should not place undue reliance on these statements. I encourage you to review the company’s filings with the SEC ...

DarioHealth (NasdaqCM:DRIO) Q4 2025 Earnings call March 19, 2026 08:30 AM ET Speaker3Good morning, ladies and gentlemen, and welcome to the DarioHealth fourth quarter and year-end 2025 results conference call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Thursday, March 19, 2026. I would now li ...